From cognitive enhancement to mood support and increased energy levels, methylene blue has gained popularity for its potential physiological benefits. Originally developed as a dye, methylene blue ...

An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to ...

The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.

Is caviar worth it? It can’t be. At Simon Johnson, 30 grams of beluga caviar costs $209. A 100-gram tin of the stuff is ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug ...

After a quiet few years Merck has returned to the category with soluble guanylate cyclase (sGC) stimulators Adempas (riociguat) and Verquvo (vericiguat) – partnered with Bayer – for PAH and ...

Safety of use during pregnancy or breastfeeding is uncertain. These drugs also act to increase intestinal fluid and intestinal movement by targeting receptors called guanylate cyclase-C (GC-C) ...

Adempas (riociguat) is the only drug in its class of soluble guanylate cyclase (sGC) stimulators. The drug is FDA-approved to treat PAH, more specifically, to improve tolerance for activity, reduce ...